SEC Filings

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

Filing date Form Description Filing Group View
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.